News
At the beginning of June, the Texas Department of State Health Services asked all programs funded by the CDC’s HIV Prevention ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
This month, lenacapavir is expected to receive FDA approval for pre-exposure prophylaxis (PrEP). It could very well be that ...
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.
Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes ...
The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...
Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, ...
The high court found that members of a task force that determines what preventive drugs must be covered can be removed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results